Mohd Altaf Bhat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mohd Altaf Bhat has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Sabia Qureshi
Sher-e-Kashmir University of Agricultural Sciences and Technology of Kashmir, Srinagar, India
3 shared publications - Isfaqul Hussain
Division of Veterinary Microbiology & Immunology, F.V.Sc & A.H, ShuhamaAlusteng, Srinagar, India
2 shared publications - Mansoor Nabi Mir2 shared publications
- Mir Nadeem Hassan2 shared publications
Najeeb Ul Tarfain
2 shared publications- Shaheen Farooq
Anaerobic Bacteriology Laboratory, Division of Veterinary Microbiology & Immunology, F.V.Sc & A.H, Shuhama (Alusteng) SKUAST-K, Srinagar-190006, India
2 shared publications
Latest Publications
- Open Access
- 28 February 2025
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 19 (1) , 498-511
Desiccation-assisted Fabrication: A Novel Method for Developing Antimicrobial Textiles in Clinical Settings Using Montmorillonite
This study introduces a novel technique called Desiccation-Assisted Fabrication for fabricating antimicrobial cotton fabrics at the point of care. This method offers a simple, rapid, and cost-effective approach to impart antimicrobial properties to cotton fabrics, enabling their use in critical healthcare settings where infection control is paramount. Different concentrations of ZnO nanoparticles (2%, 2.5%, and 3% w/v) in alkaline water (pH 8.5) were prepared, drawn into a syringe, agitated for uniform dispersion, and precisely deposited onto cotton fabric. The fabric was placed on a natural desiccant powder (montmorillonite) to remove moisture, facilitating nanoparticle adhesion through physical adsorption. Subsequent heating thermofixed the nanoparticles onto the fabric. Characterization methods such as field emission scanning electron microscopy (FESEM), X-ray diffraction (XRD), and energy-dispersive X-ray spectroscopy (EDS) confirm the consistent dispersion of zinc oxide (ZnO) nanoparticles across the coated fabric. Antimicrobial activity testing against E. coli and Staphylococcus aureus demonstrated the effectiveness of the fabric in inhibiting bacterial growth. The ability to precisely control the amount of nanoparticle deposition ensures consistent and reproducible results. This novel coating technique offers a simple, efficient, and cost-effective approach for applying metal oxide nanoparticles to textiles, particularly for small-scale or prototyping applications. However, it also holds the potential for automation, paving the way for large-scale production.
- 28 February 2025
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 19 (1) , 498-511
Open AccessDesiccation-assisted Fabrication: A Novel Method for Developing Antimicrobial Textiles in Clinical Settings Using Montmorillonite
This study introduces a novel technique called Desiccation-Assisted Fabrication for fabricating antimicrobial cotton fabrics at the point of care. This method offers a simple, rapid, and cost-effective approach to impart antimicrobial properties to cotton fabrics, enabling their use in critical healthcare settings where infection control is paramount. Different concentrations of ZnO nanoparticles (2%, 2.5%, and 3% w/v) in alkaline water (pH 8.5) were prepared, drawn into a syringe, agitated for uniform dispersion, and precisely deposited onto cotton fabric. The fabric was placed on a natural desiccant powder (montmorillonite) to remove moisture, facilitating nanoparticle adhesion through physical adsorption. Subsequent heating thermofixed the nanoparticles onto the fabric. Characterization methods such as field emission scanning electron microscopy (FESEM), X-ray diffraction (XRD), and energy-dispersive X-ray spectroscopy (EDS) confirm the consistent dispersion of zinc oxide (ZnO) nanoparticles across the coated fabric. Antimicrobial activity testing against E. coli and Staphylococcus aureus demonstrated the effectiveness of the fabric in inhibiting bacterial growth. The ability to precisely control the amount of nanoparticle deposition ensures consistent and reproducible results. This novel coating technique offers a simple, efficient, and cost-effective approach for applying metal oxide nanoparticles to textiles, particularly for small-scale or prototyping applications. However, it also holds the potential for automation, paving the way for large-scale production.
- Open Access
- 7 February 2025
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 19 (1) , 255-262
Development of a Serogroup B Specific Footrot Vaccine with Montanide ISA 61 VG Adjuvant for Prophylactic and Therapeutic Use in Sheep
Virulent footrot represents as a significant contagious ailment affecting sheep, with Dichelobacter nodosus being the primary agent responsible for transmitting the disease. Vaccinations and various management practices are utilized to control the disease. In this study, we cultured D. nodosus in broth culture under reducing conditions and formulated a vaccine using Montanide oil as adjuvant. The efficacy of the vaccine was assessed in sheep to determine its ability to elicit an effective immune response and its therapeutic potential. D. nodosus serogroup B (JKS-07B strain) was grown in a modified TAS broth and a whole cell killed vaccine was prepared using 1.5 × 109 cells per dose, along with the oil adjuvant Montanide ISA 61 VG. The vaccine trial was conducted in sheep and two doses of the vaccine were given subcutaneously with a 30 days interval between the doses. The serum antibody titers in the vaccinated animals were measured at 0, 30, 60, 90, 120, and 150 days post-vaccination using the microplate agglutination test. Protective antibody titers (≥ 3000) were achieved by the 30th day following the primary vaccination in all animals, reaching their peak at the 60th day. The protective level of antibody titers was maintained up to 120 days following the primary vaccination. The vaccine also demonstrated a therapeutic effect in animals that were clinically affected. Animals with a lesion score of 2 took 18-21 days for recovery, while those with a lesion score of 3-4 took 40-47 days to recover from lameness.
- 7 February 2025
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 19 (1) , 255-262
Open AccessDevelopment of a Serogroup B Specific Footrot Vaccine with Montanide ISA 61 VG Adjuvant for Prophylactic and Therapeutic Use in Sheep
Virulent footrot represents as a significant contagious ailment affecting sheep, with Dichelobacter nodosus being the primary agent responsible for transmitting the disease. Vaccinations and various management practices are utilized to control the disease. In this study, we cultured D. nodosus in broth culture under reducing conditions and formulated a vaccine using Montanide oil as adjuvant. The efficacy of the vaccine was assessed in sheep to determine its ability to elicit an effective immune response and its therapeutic potential. D. nodosus serogroup B (JKS-07B strain) was grown in a modified TAS broth and a whole cell killed vaccine was prepared using 1.5 × 109 cells per dose, along with the oil adjuvant Montanide ISA 61 VG. The vaccine trial was conducted in sheep and two doses of the vaccine were given subcutaneously with a 30 days interval between the doses. The serum antibody titers in the vaccinated animals were measured at 0, 30, 60, 90, 120, and 150 days post-vaccination using the microplate agglutination test. Protective antibody titers (≥ 3000) were achieved by the 30th day following the primary vaccination in all animals, reaching their peak at the 60th day. The protective level of antibody titers was maintained up to 120 days following the primary vaccination. The vaccine also demonstrated a therapeutic effect in animals that were clinically affected. Animals with a lesion score of 2 took 18-21 days for recovery, while those with a lesion score of 3-4 took 40-47 days to recover from lameness.
- Open Access
- 1 September 2023
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 17 (3) , 1679-1690
Genomic Determinants and Antimicrobial Resistance Pattern of Clinical Isolates of Extended Spectrum Beta Lactamase (ESBL) Producing Escherichia coli
The growing prevalence of antibiotic-resistant bacteria is a worldwide public health apprehension, and Escherichia coli (E. coli) is one of the most commonly implicated bacterial species. Among E. coli isolates, extended-spectrum β-lactamase (ESBL)-producing strains have been identified as a key contributor to antibiotic resistance. Penicillin’s, cephalosporins, and monobactams are only a few of the β-lactam antibiotics that can be rendered inactive by ESBLs. This investigation’s goals were to determine the prevalence of ESBL-producing E. coli isolates found in clinical samples and to analyze the distribution of the blaTEM, blaSHV, and blaCTX-M genes among them. Additionally, we aimed to determine the antibiotic susceptibility patterns of these isolates to other antibiotics. Clinical isolates from urine, ear swab, and wound/pus swabs were collected from patients with suspected E. coli bacterial infections from different regions of north India viz., SKIMS-JVC medical college and NABL accredited Dr. Qadri’s Lab both from Srinagar Kashmir valley region and SMSR, SU from Greater Noida UP. Standard laboratory techniques were used to identify E. coli isolates, and the combined disc method and other phenotypic confirmation techniques were used to confirm ESBL formation. PCR amplification and sequencing were used to find the blaTEM, blaSHV, and blaCTX-M genes. The Kirby-Bauer disc diffusion method was used to test the antimicrobial susceptibility of various bacteria to different antibiotics. A total of 210 E. coli isolates were collected from different clinical samples and only 158 isolates showed positive results for ESBL by DDST and phenotypic confirmatory tests. Of these, 124 (78.48%) were ESBL-producing isolates. We found that blaTEM was the most prevalent gene (45.16%), followed by blaCTX-M (34.16%) and blaSHV (12.09%). Antimicrobial resistance profiles were assessed for each of the 120 isolates. Ampicillin and Cefepime were the most resistant drugs to ESBL-producing isolates, followed by Gentamicin, Ceftriaxone, and Cefixime.
- 1 September 2023
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 17 (3) , 1679-1690
Open AccessGenomic Determinants and Antimicrobial Resistance Pattern of Clinical Isolates of Extended Spectrum Beta Lactamase (ESBL) Producing Escherichia coli
The growing prevalence of antibiotic-resistant bacteria is a worldwide public health apprehension, and Escherichia coli (E. coli) is one of the most commonly implicated bacterial species. Among E. coli isolates, extended-spectrum β-lactamase (ESBL)-producing strains have been identified as a key contributor to antibiotic resistance. Penicillin’s, cephalosporins, and monobactams are only a few of the β-lactam antibiotics that can be rendered inactive by ESBLs. This investigation’s goals were to determine the prevalence of ESBL-producing E. coli isolates found in clinical samples and to analyze the distribution of the blaTEM, blaSHV, and blaCTX-M genes among them. Additionally, we aimed to determine the antibiotic susceptibility patterns of these isolates to other antibiotics. Clinical isolates from urine, ear swab, and wound/pus swabs were collected from patients with suspected E. coli bacterial infections from different regions of north India viz., SKIMS-JVC medical college and NABL accredited Dr. Qadri’s Lab both from Srinagar Kashmir valley region and SMSR, SU from Greater Noida UP. Standard laboratory techniques were used to identify E. coli isolates, and the combined disc method and other phenotypic confirmation techniques were used to confirm ESBL formation. PCR amplification and sequencing were used to find the blaTEM, blaSHV, and blaCTX-M genes. The Kirby-Bauer disc diffusion method was used to test the antimicrobial susceptibility of various bacteria to different antibiotics. A total of 210 E. coli isolates were collected from different clinical samples and only 158 isolates showed positive results for ESBL by DDST and phenotypic confirmatory tests. Of these, 124 (78.48%) were ESBL-producing isolates. We found that blaTEM was the most prevalent gene (45.16%), followed by blaCTX-M (34.16%) and blaSHV (12.09%). Antimicrobial resistance profiles were assessed for each of the 120 isolates. Ampicillin and Cefepime were the most resistant drugs to ESBL-producing isolates, followed by Gentamicin, Ceftriaxone, and Cefixime.
- Open Access
- 1 January 2022
- Published by Malque Publishing in Applied Veterinary Research
- Vol. 1 (1) , 1-5
Susceptibility pattern in methicillin-resistant Staphylococcus aureus (MRSA) isolated from bovine mastitis
The study was conducted to determine the phenotypic and genotypic antimicrobial resistance pattern of methicillin resistant Staphylococcus aureus (MRSA) isolates from bovine mastitis. A total of 160 milk samples were collected aseptically from mastitis affected cows at organized dairy farms in and around Jammu and were subjected to microbial culture for the isolation and identification of methicillin resistant S. aureus using Baird Parker Agar. Out of the total 52 Staphylococcus aureus isolates, methicillin resistance (MRSA) was recorded in only 17 (32.69%) isolates out of which 7 (41.17%) isolates carried mecA gene. Susceptibility pattern of the MRSA isolates to other antibiotics revealed highest sensitivity towards enrofloxacin (100%) and lowest towards penicillin (5.88%). Multidrug resistance (MDR) was observed in 82.35% MRSA isolates. It is concluded that enrofloxacin is the most effective drug against mastitis in terms of sensitivity but undue use of the drug must be avoided to prevent the development of resistance against this drug in the near future. Hence, accurate diagnosis of bovine mastitis along with the correct selection of antibiotic is the key to prevent this devastating disease in dairy cows.
- 1 January 2022
- Published by Malque Publishing in Applied Veterinary Research
- Vol. 1 (1) , 1-5
Open AccessSusceptibility pattern in methicillin-resistant Staphylococcus aureus (MRSA) isolated from bovine mastitis
The study was conducted to determine the phenotypic and genotypic antimicrobial resistance pattern of methicillin resistant Staphylococcus aureus (MRSA) isolates from bovine mastitis. A total of 160 milk samples were collected aseptically from mastitis affected cows at organized dairy farms in and around Jammu and were subjected to microbial culture for the isolation and identification of methicillin resistant S. aureus using Baird Parker Agar. Out of the total 52 Staphylococcus aureus isolates, methicillin resistance (MRSA) was recorded in only 17 (32.69%) isolates out of which 7 (41.17%) isolates carried mecA gene. Susceptibility pattern of the MRSA isolates to other antibiotics revealed highest sensitivity towards enrofloxacin (100%) and lowest towards penicillin (5.88%). Multidrug resistance (MDR) was observed in 82.35% MRSA isolates. It is concluded that enrofloxacin is the most effective drug against mastitis in terms of sensitivity but undue use of the drug must be avoided to prevent the development of resistance against this drug in the near future. Hence, accurate diagnosis of bovine mastitis along with the correct selection of antibiotic is the key to prevent this devastating disease in dairy cows.